100.39
前日終値:
$100.83
開ける:
$101.38
24時間の取引高:
699.72K
Relative Volume:
1.10
時価総額:
$4.94B
収益:
$338.46M
当期純損益:
$-310.96M
株価収益率:
-15.37
EPS:
-6.53
ネットキャッシュフロー:
$-132.82M
1週間 パフォーマンス:
-8.47%
1か月 パフォーマンス:
-2.87%
6か月 パフォーマンス:
-2.02%
1年 パフォーマンス:
+16.02%
Axsome Therapeutics Inc Stock (AXSM) Company Profile
名前
Axsome Therapeutics Inc
セクター
電話
(212) 332-3241
住所
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
AXSM を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
AXSM
Axsome Therapeutics Inc
|
100.39 | 4.96B | 338.46M | -310.96M | -132.82M | -6.53 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-03 | 再開されました | Morgan Stanley | Overweight |
2025-06-03 | 開始されました | Oppenheimer | Outperform |
2025-04-07 | 開始されました | Jefferies | Buy |
2025-02-11 | 開始されました | Deutsche Bank | Buy |
2024-12-31 | 繰り返されました | Mizuho | Outperform |
2024-09-03 | 開始されました | Wells Fargo | Overweight |
2024-08-06 | アップグレード | BofA Securities | Neutral → Buy |
2024-07-22 | 開始されました | Needham | Buy |
2024-04-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2024-03-19 | 開始されました | Robert W. Baird | Outperform |
2024-02-06 | 開始されました | UBS | Buy |
2024-01-25 | 開始されました | RBC Capital Mkts | Outperform |
2023-12-13 | 開始されました | Citigroup | Buy |
2023-08-08 | アップグレード | BofA Securities | Underperform → Neutral |
2023-01-05 | 開始されました | Piper Sandler | Neutral |
2022-11-01 | 開始されました | Loop Capital | Buy |
2022-09-07 | 再開されました | Mizuho | Buy |
2021-08-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2021-06-10 | 開始されました | Berenberg | Buy |
2021-01-08 | 開始されました | Jefferies | Buy |
2020-12-16 | 開始されました | Mizuho | Buy |
2020-09-29 | 開始されました | BofA Securities | Underperform |
2020-09-10 | 開始されました | Morgan Stanley | Overweight |
2020-04-28 | 繰り返されました | H.C. Wainwright | Buy |
2020-04-14 | 開始されました | Cowen | Outperform |
2019-12-30 | 繰り返されました | H.C. Wainwright | Buy |
2019-12-17 | 繰り返されました | H.C. Wainwright | Buy |
2019-12-16 | 繰り返されました | Guggenheim | Buy |
2019-10-16 | 開始されました | Guggenheim | Buy |
2019-09-18 | 開始されました | William Blair | Outperform |
2019-05-28 | 開始されました | SunTrust | Buy |
2019-05-23 | 繰り返されました | H.C. Wainwright | Buy |
2019-04-08 | 開始されました | SVB Leerink | Outperform |
2019-03-15 | 繰り返されました | H.C. Wainwright | Buy |
2016-10-03 | 再開されました | Brean Capital | Buy |
2015-12-15 | 開始されました | Cantor Fitzgerald | Buy |
2015-12-14 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Axsome Therapeutics Inc (AXSM) 最新ニュース
Axsome Therapeutics Inc.’s Price Action Aligns with Quant SignalsTriple Digit Return Stock Predictions Released - metal.it
Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
What makes Axsome Therapeutics Inc. stock price move sharplyStock Strategy Planner To Watch Now - jammulinksnews.com
Envestnet Asset Management Inc. Sells 10,086 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics (AXSM) to Release Earnings on Monday - MarketBeat
Why is Axsome Therapeutics Inc. stock attracting strong analyst attentionAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
Royce & Associates LP Sells 6,743 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
What catalysts could drive Axsome Therapeutics Inc. stock higher in 2025Invest confidently with real-time data analysis - jammulinksnews.com
Does Axsome Therapeutics Inc. stock perform well during market downturnsGet timely alerts on market opportunities - jammulinksnews.com
Universal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Cwm LLC Trims Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Y Intercept Hong Kong Ltd Makes New $1.49 Million Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
How strong is Axsome Therapeutics Inc. company’s balance sheetFree Market Dynamics Reports - jammulinksnews.com
Axsome Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Stock Market Query - metal.it
Published on: 2025-07-27 23:41:07 - jammulinksnews.com
Is Axsome Therapeutics Inc. stock overvalued or undervaluedDynamic profit expansion - jammulinksnews.com
When is Axsome Therapeutics Inc. stock expected to show significant growth - jammulinksnews.com
How does Axsome Therapeutics Inc. generate profit in a changing economyUnprecedented profit potential - jammulinksnews.com
Knights of Columbus Asset Advisors LLC Sells 4,957 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Q3 EPS Estimate for Axsome Therapeutics Raised by Analyst - MarketBeat
Axsome Therapeutics: Navigating Setbacks with a Strong Pipeline and Analyst Confidence - AInvest
Axsome: Some Recent Setbacks, Some Recent Wins — Still A Buy (NASDAQ:AXSM) - Seeking Alpha
Axsome Therapeutics (NASDAQ:AXSM) Shares Down 5.6%Here's Why - MarketBeat
Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline - ADVFN Brasil
Why Axsome Therapeutics Inc. stock is on top investor watchlistsSuperior stock selection - jammulinksnews.com
What analysts say about Axsome Therapeutics Inc. stockOutstanding capital growth - Autocar Professional
Axsome Therapeutics Inc. Stock Analysis and ForecastRapid growth trajectories - PrintWeekIndia
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stake Raised by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. - MarketBeat
RBC Capital Sticks to Their Buy Rating for Axsome Therapeutics (AXSM) - The Globe and Mail
New York State Common Retirement Fund Has $3.92 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Is Axsome Therapeutics Inc. stock overhyped or has real potentialUnstoppable trading performance - jammulinksnews.com
How high can Axsome Therapeutics Inc. stock price go in 2025Breakthrough investment results - jammulinksnews.com
How To Trade (AXSM) - news.stocktradersdaily.com
Axsome Therapeutics Settles SUNOSI (Solriamfetol) Patent Litigation With Hetero Labs Ltd. - 富途牛牛
Is This Stock a Buy After Soaring by 20% in 1 Day? - AOL.com
2 Top Stocks I Wouldn't Hesitate to Invest $1,000 in Right Now - MSN
Legato Capital Management LLC Buys New Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics to Ring the NASDAQ Stock Market Opening Bell Today - 富途牛牛
Is Axsome Therapeutics Inc. a good long term investmentGame-changing returns - Autocar Professional
Leerink Partners Keeps Bullish Stance on Axsome Therapeutics with Buy Rating - AInvest
Lindbrook Capital LLC Cuts Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Optimistic Outlook for Axsome Therapeutics: Promising Pipeline and Potential Sales Growth Drive Buy Rating - TipRanks
Axsome Therapeutics Breaks Below 200-Day Moving AverageNotable for AXSM - Nasdaq
What drives Axsome Therapeutics Inc. stock priceUnprecedented profit potential - jammulinksnews.com
Readystate Asset Management LP Invests $6.95 Million in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
ALKS Down Despite Positive Top-Line Data From Narcolepsy Study - The Globe and Mail
Axsome Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com Canada
Axsome Therapeutics Inc (AXSM) 財務データ
収益
当期純利益
現金流量
EPS
Axsome Therapeutics Inc (AXSM) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Murdock Hunter R. | General Counsel |
Jun 23 '25 |
Option Exercise |
29.91 |
6,014 |
179,879 |
6,014 |
Murdock Hunter R. | General Counsel |
Jun 20 '25 |
Sale |
102.47 |
7,500 |
768,525 |
0 |
Murdock Hunter R. | General Counsel |
Jun 23 '25 |
Sale |
100.12 |
6,014 |
602,122 |
0 |
大文字化:
|
ボリューム (24 時間):